Chiltern
Established in 1982 and with experience in over 40 countries, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Uniphar
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Company Details
Latest Content from PMHub
Infographic: Are data blind spots putting your launch at risk?
White Papers and Resources | July 16, 2026 | Inizio
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult to understand market readiness, prioritize...
Key takeaways from ASCO® 2026
White Papers and Resources | July 16, 2026 | Inizio
Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year's congress revealed for pharmaceutical organisations. Together, they...
More Than Pink Walls: What Women-Centric Care Actually Requires
Press Releases | July 15, 2026 | Medscape Education
The phrase "patient-centered care" is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the population, that promise routinely fractures. In the latest episode of the Hear...
Why faster trials make participant understanding more important than ever
White Papers and Resources | July 15, 2026 | Cuttsy + Cuttsy
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Real Chemistry Launches Real Chemistry ANATOMI, an AI Ecosystem Purpose-Built for Healthcare Commercialization
Press Releases | July 14, 2026 | Real Chemistry
The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of business growth and client value
Older trial participants reject bad design, not technology
White Papers and Resources | July 8, 2026 | Cuttsy + Cuttsy
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
5 key takeaways from the Patient Centricity and Engagement Conference
White Papers and Resources | July 2, 2026 | Cuttsy + Cuttsy
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
Women in Healthcare Leadership Have a Lot to Say. Medscape’s Hear From Her Wins an APEX Grand Award.
Press Releases | July 2, 2026 | Medscape Education
Medscape Education has been honoured with the prestigious APEX Grand Award for Publication Excellence at...
Moving Beyond the 10%: A New Era in Preterm Birth Prevention
Press Releases | July 1, 2026 | Medscape Education
For decades, the rate of spontaneous preterm birth in the United States has hovered stubbornly around 10%. Despite advancements in other areas of medicine, prematurity remains the second leading cause...
It’s time to stop calling adverse events ‘manageable’
White Papers and Resources | June 29, 2026 | Cuttsy + Cuttsy
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.